Increased hypoxic burden was associated with major cardiovascular and cerebrovascular adverse events (MACCE) in patients with OSA.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio A Virginia-based biotech company has ...

In a recent study published in Respiratory Medicine, researchers reported that silent hypoxia was not unique to coronavirus disease 2019 (COVID-19). Silent hypoxemia syndrome, well-tolerated hypoxemia ...

Adults with mild to severe obstructive sleep apnea achieved lower disease severity with AD109, an oral combination drug, at ...

Tumor hypoxia on 18F-fluoromisonidazole (FMISO) positron emission tomography (PET) may serve as a reliable clinical biomarker of distant metastasis risk for patients with head and neck squamous cell ...

Uganda’s new Hypoxia Lab takes lead in ensuring patient safety isn’t skin colour dependent HEALTH FEATURE | PATRICIA ...

NORFOLK, Va.--(BUSINESS WIRE)--ReAlta Life Sciences (“ReAlta”), Inc., a clinical mid-stage biotech company dedicated to addressing life-threatening rare diseases by harnessing the power of the immune ...